John C. Lee

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

R R Osborn, D E Griswold, J. Adams, 2000, The Journal of pharmacology and experimental therapeutics.

Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.

J. Lee, N. Hanna, B. Votta, 1988, International journal of immunopharmacology.

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

J. Boehm, J. Adams, T. Gallagher, 1996, Journal of medicinal chemistry.